More importantly, we showed that the co-expression of FasL and FADD could elicit potent anti-tumor effect, which was enhanced in the presence of temozolomide, resulting in prolonged survival of mice bearing orthotopic gliomas. This evidence concerns the gene FADD and central nervous system cancer.